Task: Answer Verification
Input (English): Question: Does the endothelin antagonist bosentan improve survival in severe experimental pancreatitis in rats?
Answer: Therapy with the mixed endothelin A and endothelin B receptor antagonist bosentan does not influence the outcome after severe experimental pancreatitis. Therefore, blockade of endothelin A and B receptor subtypes may not be of major importance as a therapeutic principle in this model of experimental pancreatitis.
Output (English): no